HYTN Launches Nano Gummies Offering ‘Faster And More Consistent Cannabis Experience’
HYTN Cannabis Inc. wholly owned subsidiary of HYTN Innovations Inc., (CSE:HYTN) has developed and listed for sale its all-new Nano Gummies product.
Khiron Q2 Revenue Grows 60% YoY, Despite Decline In Medical Cannabis Sales In Germany
Khiron Life Sciences Corp. (TSXV:KHRN) (OTCQX: KHRNF) (Frankfurt:A2JMZC) Q2 2022 total revenue was CA$4.5 million ($3.45 million), up 60% year-over-year, driven by growth in the medical cannabis segment in Colombia and the United Kingdom.
Jushi’s NuLeaf Acquisition Pays-Off, Strong Q2 Revenue Growth, Provides Outlook
Jushi Holdings Inc. (OTCQX: JUSHF) (CSE:JUSH) released its financial results for the second quarter 2022 ended June 30, 2022, revealing total revenue of $72.8 million, an increase of 52.4% year-over-year and 17.6% as compared to Q1 2022.
[Video] Why This Billionaire Is Excited About Cannabis In Europe
"I'm super excited about Europe," said Boris Jordan of Curaleaf Holdings Inc (OTC: CURLF) at the Benzinga Cannabis Capital Conference held last April.
Breaking Down The Best Cannabis Operators By Environmental Impact, Meet Them At Benzinga Cannabis Capital Conference
The Sept. 13-14 Benzinga Cannabis Capital Conference in Chicago will celebrate, among so many other things, the shared commitment to caring for Mother Earth.
Elon Musk Calls This Drug The ‘Most Troubling’: Is It Marijuana, LSD, Speed, Or Caffeine?
Elon Musk on Friday weighed in on the impact of different classes of psychoactive drugs.
Marijuana Stock Movers For August 26, 2022
GAINERS:
Charlottes Web Holdings (OTC:CWBHF) shares closed up 10.34% at $0.64
Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today
GAINERS:
Cybin (AMEX:CYBN) shares closed up 3.61% at $1.00
LOSERS:
New York’s Medical Cannabis Companies Seek A Less Pricey Route To Go Recreational
Medical cannabis operators in New York are worried about having to pay an exorbitant fee in order to go recreational.
According to the New York Times, in order to sell marijuana outside of a medical program, multi-state operators (MSOs) must pay a fee of $20 million.
Jimi Devine’s Dream Job: How This Guy Became A Hashish Judge And Cannabis Reviewer
Via El Planteo - Original publication: September 8, 2021.